Skip to content
HomeMedia CenterPress releases FinancialJohnson & Johnson to Participate in the Raymond James 45th Annual Institutional Investors Conference

Johnson & Johnson to Participate in the Raymond James 45th Annual Institutional Investors Conference

Share Article
share to

New Brunswick, N.J., February 1st, 2024 Johnson & Johnson (NYSE: JNJ) will participate in the Raymond James 45th Annual Institutional Investors Conference on Tuesday, March 5th, at the JW Marriott Orlando Grande Lakes, Orlando, FL. Ahmet Tezel, Company Group Chairman, MedTech R&D will represent the Company in a session scheduled at 2:15 p.m. (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

Media contact:
media-relations@its.jnj.com

Investor contact:
investor-relations@its.jnj.com

You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.